Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients
December 25, 2022
![](https://mj-lab.mgh.harvard.edu/wp-content/uploads/2022/12/09opioid-disparity2-jumbo1.jpg)
Researchers have long known that racial and ethnic minorities are less likely to be prescribed lifesaving addiction treatment options than white people.
But even when Black and Hispanic patients start a prescription for buprenorphine — the most popular medication to help those in recovery fight cravings — the typical duration of their treatment is shorter than that of white patients, according to a new data analysis published Wednesday in JAMA Psychiatry.
The analysis, which sorted through 15 years of prescription data… read more on New York Times